{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Tejnaksh Healthcare Ltd
Tejnaksh Healthcare Ltd is Rated Strong Sell
Tejnaksh Healthcare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 03 Dec 2025. However, all fundamentals, returns, and financial metrics discussed below reflect the stock’s current position as of 26 December 2025, providing investors with the latest insights into the company’s performance and outlook.
Why is Tejnaksh Health. falling/rising?
On 12-Dec, Tejnaksh Healthcare Ltd’s stock price fell to ₹15.00, down by ₹0.12 or 0.79%, continuing a sustained period of underperformance relative to the broader market and its sector peers.
Tejnaksh Healthcare Stock Falls to 52-Week Low of Rs.14.01 Amidst Prolonged Underperformance
Tejnaksh Healthcare’s shares reached a fresh 52-week low of Rs.14.01 today, marking a significant decline amid ongoing challenges in the healthcare services sector. The stock’s performance continues to trail behind key market indices and sector benchmarks, reflecting persistent pressures on the company’s financial metrics and valuation.
Tejnaksh Healthcare Stock Falls to 52-Week Low of Rs.15.15
Tejnaksh Healthcare has reached a new 52-week low, with its share price touching Rs.15.15 today. This marks a significant decline for the healthcare services company amid broader market fluctuations and ongoing performance concerns.
Tejnaksh Healthcare Faces Market Assessment Shift Amidst Challenging Financial and Technical Trends
Tejnaksh Healthcare, a player in the healthcare services sector, has recently experienced a notable shift in market evaluation metrics. This change reflects a complex interplay of technical indicators, valuation considerations, financial trends, and quality assessments, highlighting the challenges the company faces amid a subdued market environment and persistent underperformance relative to benchmarks.
How has been the historical performance of Tejnaksh Health.?
Tejnaksh Health's historical performance shows fluctuating net sales and profits, with a decline from Mar'19 to Mar'20, followed by recovery; net sales rose to 12.90 Cr in Mar'25 from 11.73 Cr in Mar'23, but cash flow from operations dropped to 0.00 Cr in Mar'25, indicating challenges despite improved profits.
Tejnaksh Healthcare Falls to 52-Week Low of Rs.16 Amid Continued Downtrend
Tejnaksh Healthcare’s stock price reached a fresh 52-week low of Rs.16 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past four consecutive sessions, reflecting ongoing pressures within the healthcare services sector.
Tejnaksh Healthcare Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals
Tejnaksh Healthcare, a player in the healthcare services sector, has experienced a notable revision in its market evaluation, reflecting a complex interplay of technical indicators, valuation metrics, financial trends, and quality assessments. This article analyses the factors influencing the recent shift in the company’s investment outlook, providing investors with a comprehensive understanding of its current position.
Tejnaksh Healthcare Stock Falls to 52-Week Low of Rs.16.02
Tejnaksh Healthcare has reached a new 52-week low, with its share price touching Rs.16.02 today. This marks a significant decline amid broader market fluctuations and ongoing challenges within the healthcare services sector.
Tejnaksh Healthcare Sees Adjustment in Evaluation Amid Technical and Financial Trends
Tejnaksh Healthcare, a key player in the Healthcare Services sector, has undergone a revision in its evaluation reflecting changes across technical indicators, financial trends, valuation metrics, and overall quality parameters. This article analyses the factors influencing the recent adjustment in the company’s score grade as of 19 Nov 2025, providing investors with a comprehensive overview of its current standing.
How has been the historical performance of Tejnaksh Health.?
Tejnaksh Health's historical performance shows fluctuating net sales, increasing from 11.73 Cr in Mar'23 to 12.90 Cr in Mar'25, but down from a peak of 19.76 Cr in Mar'19. While profitability has improved, total assets and sales remain below historical highs.
Why is Tejnaksh Health. falling/rising?
As of 18-Nov, Tejnaksh Healthcare Ltd's stock price is Rs 16.50, down 1.61%, and has declined 3.34% over the last two days. The stock is underperforming significantly compared to the Sensex, trading below all major moving averages and nearing its 52-week low.
How has been the historical performance of Tejnaksh Health.?
Tejnaksh Health has shown a recovery in net sales and profits from Mar'21 onwards, with net sales increasing from 11.73 Cr in Mar'23 to 12.90 Cr in Mar'25, while profit after tax rose from 1.79 Cr to 2.23 Cr in the same period. However, total operating income peaked in Mar'19 and has since declined, alongside rising operational costs and a decrease in total liabilities.
Tejnaksh Healthcare Adjusts Evaluation Score Amid Mixed Technical Indicators and Market Challenges
Tejnaksh Healthcare has recently adjusted its evaluation score, reflecting a shift in technical trends. The company's mixed technical indicators show both mildly bullish and bearish signals. Despite facing a significant decline in stock performance over the past year, its valuation remains attractive compared to peers.
Tejnaksh Healthcare Q2 FY26: Sharp Profit Decline Amid Revenue Struggles
Tejnaksh Healthcare Ltd., a micro-cap healthcare services provider with a market capitalisation of ₹36.52 crores, reported a disappointing second quarter for FY2026, with consolidated net profit plunging 50.00% year-on-year to ₹0.31 crores despite a sequential recovery of 24.00% from Q1 FY26. The company's shares, trading at ₹17.98, have declined 25.39% over the past year, significantly underperforming the healthcare services sector's 21.41% gain.
How has been the historical performance of Tejnaksh Health.?
Tejnaksh Health's historical performance shows fluctuating net sales and profits, with a recovery from a decline between Mar'20 and Mar'21. As of Mar'25, net sales reached 12.90 Cr, operating profit improved to 4.08 Cr, and profit after tax was 2.23 Cr, despite challenges in revenue growth and cash flow management.
Are Tejnaksh Health. latest results good or bad?
Tejnaksh Healthcare's latest results are concerning, showing a 15.38% decline in net sales and a 43.93% drop in operating profit compared to the previous year, indicating significant operational challenges. Key metrics like profit before tax and earnings per share have also decreased, reflecting a tough financial environment for the company.
Tejnaksh Healthcare Adjusts Evaluation Score Amid Mixed Technical Indicators and Performance Challenges
Tejnaksh Healthcare has recently adjusted its evaluation score, reflecting a shift in technical trends. The company's indicators present a mixed outlook, with some showing bullish signals while others indicate bearish trends. Despite facing performance challenges, the stock is trading at a discount compared to its peers.
How has been the historical performance of Tejnaksh Health.?
Tejnaksh Health has shown fluctuating financial performance, with net sales increasing from INR 11.73 crore in March 2023 to INR 12.90 crore in March 2025, and profitability improving, as profit after tax rose to INR 2.23 crore in March 2025. However, total assets and liabilities decreased, and cash flow from operating activities dropped to zero in March 2025.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
